Adenocarcinoma of the Cervix

Gynecologic Cancer: Controversies in Management

Volumn , Issue , 2004, Pages 149-160

  Hopkins, Michael P ^a   Smith, Harriet O ^b  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 33745932929     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-0-443-07142-3.50015-4     Document Type: Chapter

References (115)

1. C Wright, A Ferenczy and RJ Kurman (1994) Carcinoma and other tumors of the cervix. RJ Kurman (Ed.) Blaustein's Pathology of the Female Genital Tract 4th ed. New York: Springer-Verlag 279-326.
2. RK Peters, A Chao, TM Mack, et al. (1986) Increased frequency of adenocarcinoma of the uterine cervix in young women in Los Angeles County. J Natl Cancer Inst 76 423-428.
3. SM Schwartz and N Weiss (1986) Increased incidence of adenocarcinoma of the cervix in young women in the United States. Am J Epidemiol 124 1045-1047.
4. H Anton-Culver, JD Bloss, D Bringman, et al. (1992) Comparison of adenocarcinoma and squamous cell carcinoma of the uterine cervix: A population based epidemiologic study. Am J Obstet Gynecol 186 1507-1514.
5. P Hopkins and GW Morley (1991) A comparison of adenocarcinoma and squamous cell carcinoma of the cervix. Obstet Gynecol 7 912-917.
6. P Nieminen, M Kallio and M Hakama (1995) The effect of mass screening on incidence and mortality of squamous and adenocarcinoma of cervix uteri. Obstet Gynecol 85 1017-1021.
7. CE Platz and JA Benda (1995) Histology of cancer, incidence and prognosis: SEER population-based data, 1973-1987, female genital tract cancer. Cancer 75 270-294.
8. HO Smith, M Tiffany, CR Qualls and CR Key (2000) The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the U.S.: A 24-year population-based study. Gynecol Oncol 78 97-105.
9. K Sigurdsson (1999) The Icelandic and Nordic cervical screening programs: Trends in incidence and mortality rates through 1995. Acta Obstet Gynecol Scand 78 478-485.
10. A Hebert, N Singh and JAE Smith (2001) Adenocarcinoma of the uterine cervix compared with squamous cell carcinoma: A 12-year study in Southampton and South-west Hampshire. Cancer Cytopathol 12 26-36.
11. P Saieni and J Adams (2001) Changing rates of adenocarcinoma and adenosquamous carcinoma of the cervix in England. Lancet 357 1490-1493.
12. GC Alfsen, SØ Thoresen, GB Kristensen, et al. (2000) Histopathologic subtyping of cervical adenocarcinoma reveals increasing incidence rates of endometrioid tumors in all age groups: A population based study with review of all nonsquamous cervical carcinomas in Norway from 1966 to 1970, 1976 to 1980, and 1986 to 1990. Cancer 89 1291-1299.
13. S Liu, R Semenciw and Y Mao (2001) Cervical cancer: The increasing incidence of adenocarcinoma and adenosquamous carcinoma in younger women. CMAJ 164 1151-1152.
14. Surveillance, Epidemiology, and End Results (SEER) Stat 4.0. (August 2000 Submission.) Bethesda, MD: U.S. Department of Health and Human Services, Public Health Service, National Institutes of Health, National Cancer Institute, Cancer Statistics Branch
15. NS Goldstein, E Ahmad, M Hussain, et al. (1998) Endocervical glandular atypia: Does a preneoplastic lesion of adenocarcinoma in situ exist? Am J Clin Pathol 110 200-209.
16. LS Massad, YC Collins and PM Meyer (2001) Biopsy correlates of abnormal cervical cytology classified using the Bethesda system. Gynecol Oncol 82 516-522.
17. SB Soofer and MK Sidawy (2000) Atypical glandular cells of undetermined significance: Clinically significant lesions and means of patient follow-up. Cancer 90 207-214.
18. AB Chin, RE Bristow, LM Korst, et al. (2000) The significance of atypical glandular cells on routine cervical cytologic testing in a community-based population. Am J Obstet Gynecol 182 1278-1282.
19. DC Chhieng, P Elgert, JM Cohen and JF Cangirella (2001) Clinical significance of atypical glandular cells of undetermined significance in postmenopausal women. Cancer 93 1-7.
20. M Schoolland, S Allpress and GF Sterrett (2002) Adenocarcinoma of the cervix: Sensitivity of diagnosis by cervical smear and cytologic patterns and pitfalls in 24 cases. Cancer Cytopathol 96 5-13.
21. D Solomon, D Davey, R Kurma, et al. (2002) The 2001 Bethesda System: Terminology for reporting results of cervical cytology. JAMA 287 2114-2119.
22. TC Wright Jr, JT Cox, LS Massad, et al. (2002) 2001 Consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 287 2120-2129.
23. RJ Zaino (2000) Glandular lesions of the uterine cervix. Mod Pathol 13 261-274.
24. RC Jaworski (1990) Endocervical glandular dysplasia, adenocarcinoma in situ, and early invasive (microinvasive) adenocarcinoma of the uterine cervix. Semin Diagn Pathol 7 190-204.
25. GH Friedell and DG McKay (1953) Adenocarcinoma in situ of the endo-cervix. Cancer 6 887-897.
26. SD Shipman and RE Bristow (2001) Adenocarcinoma in situ and early invasive adenocarcinoma of the uterine cervix. Curr Opin Oncol 13 394-398.
27. SC Plaxe and L Saltzstein (1999) Estimation of the duration of the preclinical phase of cervical adenocarcinoma suggests that there is ample opportunity for screening. Gynecol Oncol 75 55-61.
28. F Parazzini and C La Vecchia (1990) Epidemiology of adenocarcinoma of the cervix. Gynecol Oncol 39 40-46.
29. S Riethdorf, L Riethdorf, K Milde-Langosh, et al. (2000) Differences in HPV 16- and HPV 19 E6/E7 oncogene expression between in situ and invasive adenocarcinomas of the cervix uteri. Virchows Archiv 437P 491-500.
30. MA Duggan, SE McGregor, JL Benot, et al. (1995) The human papillo-mavirus status of invasive cervical adenocarcinoma: A clinico-pathological and outcome analysis. Hum Pathol 2 319-325.
31. BM Skyldherg, E Murray, H Lambkin, et al. (1999) Adenocarcinoma of the uterine cervix in Ireland and Sweden: Human papillomavirus infection and biologic alterations. Mod Pathol 12 675-682.
32. JMM Walboomers, MV Jacobs, MM Manos, et al. (1999) Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 189 12-19.
33. Z Bosch, MM Manos, N Munoz, et al. (1995) Prevalence of human papillomavirus in cervical cancer: A worldwide perspective. J Natl Cancer Inst 87 796-802.
34. KL Wallin, F Wiklund, T Angströam, et al. (1999) Type-specific persistence of human papillomavirus DNA before the development of invasive cervical cancer. N Engl J Med 341 1633-1638.
35. MM Madeleine, JR Daling, SM Schwartz, et al. (2001) Human papillomavirus and long-term oral contraceptive use increase the risk of adenocarcinoma in situ of the cervix. Cancer Epidemiol Biol Prevention 10 171-177.
36. LA Brinton, KT Tashima, HF Leman, et al. (1987) Epidemiology of cervical cancer by cell type. Cancer Res 47 1706-1711.
37. JV Lacey Jr, M Frisch, LA Brinton, et al. (2001) Associations between smoking and adenocarcinomas and squamous cell carcinomas of the uterine cervix (United States). Cancer Cause Control 12 153-161.
38. G Ursin, RK Peters, BE Henderson, et al. (1994) Oral contraceptive use and adenocarcinoma of the cervix. Lancet 344 1380-1394.
39. X Lu, T Shiozawa, K Nakayama, et al. (1999) Abnormal expression of sex steroid receptors and cell cycle-related molecules in adenocarcinoma in situ of the uterine cervix. Int J Gynecol Pathol 18 109-114.
40. JV Lacey Jr, LA Brinton, WA Barnes, et al. (2000) Use of hormone replacement therapy and adenocarcinomas and squamous cell carcinomas of the uterine cervix. Gynecol Oncol 77 149-154.
41. V Moreno, FX Bosch, N Munoz, et al. (2002) Effect of oral contraceptives on risk of cervical cancer in women with human papillomavirus infection: The IARC multicentre case-control study. Lancet 259 1085-1092.
42. N Munoz, S Francheschi, C Bosetti, et al. (2002) Role of parity and human papillomavirus in cervical cancer: The IARC multicentre case-control study. Lancet 359 1093-1101.
43. BM Ronnett, MM Manos, JE Ransley, et al. (1999) Atypical glandular cells of undetermined significance (AGUS): Cytopathologic features, histopathologic results, and human papillomavirus DNA detection. Hum Pathol 30 816-825.
44. M Azodi, SK Chambers, TJ Rutherford, et al. (1999) Adenocarcinoma in situ of the cervix: Management and outcome. Gynecol Oncol 73 348-353.
45. NS Goldstein and A Mani (1998) The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol 109 727-732.
46. TR Denehy, CA Gregor and JL Breen (1997) Endocervical curettage, cone margins, and residual adenocarcinoma in situ of the cervix. Obstet Gynecol 90 1-6.
47. AG Östör, R Pagano, RAM Davoren, et al. (1984) Adenocarcinoma in situ of the cervix. Int J Gynecol Pathol 3 179-190.
48. KR Lee (1999) Adenocarcinoma in situ with a small cell (endometrioid) pattern in cervical smears. Cancer Cytopathol 87 254-258.
49. JS Berek, NF Hacker, Y-S Fu, et al. (1985) Adenocarcinoma of the uterine cervix: Histologic variables associated with lymph node metastasis and survival. Obstet Gynecol 46 46-52.
50. ES Anderson and E Arffmann (1989) Adenocarcinoma in situ of the uterine cervix: A clinico-pathologic study of 36 cases. Gynecol Oncol 35 1-7.
51. MP Hopkins, JA Roberts and RW Schmidt (1988) Cervical adenocarcinoma in situ. Obstet Gynecol 71 842-844.
52. NS Goldstein and A Mani (1998) The status and distance of cone biopsy margins as a predictor of excision adequacy for endocervical adenocarcinoma in situ. Am J Clin Pathol 109 727-732.
53. IJ Etherington and DM Luesley (2001) Adenocarcinoma in situ of the cervix: Controversies in diagnosis and treatment. J Lower Gen Tract Dis 5 94-98.
54. DD Im, LR Duska and NB Boenshein (1995) Adequacy of conization margins in adenocarcinoma in situ of the cervix as a predictor of residual disease. Gynecol Oncol 59 179-182.
55. A Poyner, RR Barakat and WJ Hoskins (1995) Management and follow-up of patients with adenocarcinoma in situ of the uterine cervix. Gynecol Oncol 57 158-164.
56. HG Muntz, DA Bell, JM Lage, et al. (1992) Adenocarcinoma in situ of the uterine cervix. Obstet Gynecol 80 935-939.
57. JK Wolf, C Levenback, A Maslpica, et al. (1996) Adenocarcinoma in situ of the cervix: Significance of cone biopsy margins. Obstet Gynecol 88 82-86.
58. MP Hopkins (2000) Adenocarcinoma in situ of the cervix: The margins must be clear. Gynecol Oncol 79 4-5.
59. T Widrich, AW Kennedy, TM Myers, et al. (1996) Adenocarcinoma in situ of the uterine cervix: Management and outcome. Gynecol Oncol 61 304-308.
60. GM Lickrish, T Colgan and VC Wright (1993) Colposcopy of adenocarcinoma in situ and invasive adenocarcinoma of the cervix. Obstet Gynecol Clin North Am 20 111-122.
61. TC Krivak, GS Rose, JW McBroom, et al. (2001) Cervical adenocarcinoma in situ: A systematic review of therapeutic options and predictors of persistent or recurrent disease. Obstet Gynecol Surv 56 567-575.
62. M Bertrand, GM Lickrish and TJ Colgan (1987) The anatomic distribution of cervical adenocarcinoma in situ: Implications for treatment. Am J Obstet Gynecol 157 21-25.
63. HN Nguyen and HE Averette (1999) Special problems in cervical cancer management. Semin Surg Oncol 16 261-266.
64. P Elliott, M Cobbleon, P Russell, et al. (2000) Early invasive (FIGO stage IA) carcinoma of the cervix: A clinico-pathologic study of 476 cases. Int J Gynecol Cancer 10 42-52.
65. JL Benedet and GH Anderson (1996) Review: Stage IA carcinoma of the cervix revisited. Obstet Gynecol 87 1052-1059.
66. T Creasman, RJ Zaino, FJ Major, et al. (1998) Early invasive carcinoma of the cervix (3 to 5 mm invasion): Risk factors and prognosis. A Gynecologic Oncology Group study. Am J Obstet Gynecol 178 62-65.
67. PR Morgan, MD Anderson, CH Buckley, et al. (1993) The Royal College of Obstetricians and Gynaecologists micro-invasive carcinoma of the cervix study: Preliminary results. Br J Obstet Gynaecol 100 664-668.
68. H Sachs, J Ikeda and AKJ Brachetti (1975) Mikroinvasives adenokarzinom and adenocarcinoma in situ der cervix uteri. Med Welt 26 1181-1183.
69. T Iversen, V Abeler and KE Kjrostad (1979) Factors influencing the treatment of patients with stage IA carcinoma of the cervix. Br J Obstet Gynaecol 86 593-597.
70. AH Qizilbash (1975) In situ and microinvasive adenocarcinoma of the uterine cervix: A clinical, cytologic and histologic study of 14 cases. Am J Clin Pathol 64 155-170.
71. K Matsukuma, N Tsukamoto, T Kaku, et al. (1989) Early adenocarcinoma of the uterine cervix: Its histologic and immunohistologic study. Gynecol Oncol 35 38-43.
72. TP Rollason, J Cullimore and MG Bradgate (1989) A suggested columnar cell morphological equivalent of squamous carcinoma in situ with early stromal invasion. Int J Gynaecol Pathol 8 230-236.
73. HG Kaspar, TV Dinh, MG Doherty, et al. (1993) Clinical implications of tumor volume measurement in stage I adenocarcinoma of the cervix. Obstet Gynecol 81 296-300.
74. CM Matthews, TW Burke, C Tornos, et al. (1993) Stage I cervical adenocarcinoma: Prognostic evaluation of surgically treated patients. Gynecol Oncol 49 19-23.
75. AW Kennedy, GH El Tabakh, CV Biscotti and S Wirth (1995) Invasive adenocarcinoma of the cervix following LLETZ (large loop excision of the transformation zone) for adenocarcinoma in situ. Gynecol Oncol 58 274-277.
76. AG Östör, R Rome and M Quinn (1997) Microinvasive adenocarcinoma of the cervix: A clinicopathologic study of 77 women. Obstet Gynecol 89 88-93.
77. JO Schorge, KR Lee, CE Flynn, et al. (1999) Stage IA1 cervical adenocarcinoma: Definition and treatment. Obstet Gynecol 93 219-222.
78. AG Östör (2000) Early invasive adenocarcinoma of the uterine cervix. Int J Gynecol Pathol 19 29-38.
79. T Kaku, T Kamura, S Kunihiro, et al. (1997) Early adenocarcinoma of the uterine cervix. Gynecol Oncol 65 281-285.
80. JC Webb, CR Key, CR Qualls and HO Smith (2001) Population-based study of microinvasive adenocarcinoma of the uterine cervix. Obstet Gynecol 97 701-706.
81. HO Smith, CR Qualls, AA Romero, et al. (2002) Is there a difference in survival for IA 1 and IA 2 adenocarcinoma of the uterine cervix? Gynecol Oncol 85 229-241.
82. P Hopkins, WA Peters, W Anderson and GW Morley (1990) Invasive cervical cancer treated initially by standard hysterectomy. Gynecol Oncol 36 7-12.
83. M McHale, TD Le, RA Burger, et al. (2001) Fertility sparing treatment for in situ and early invasive adenocarcinoma of the cervix. Obstet Gynecol 98 726-731.
84. NP Nagarsheth, GL Maxwell, RC Bentle and G Rodriguez (2000) Bilateral pelvic lymph node metastases in a case of FIGO stage IA 1 adenocarcinoma of the cervix. Gynecol Oncol 77 467-470.
85. G Zanetta, A Gabriele, F Veccione, et al. (2000) Unusual recurrence of cervical adenosquamous carcinoma after conservative surgery. Gynecol Oncol 76 409-412.
86. K Utsugi, Y Shimizu, F Akyama and K Hasmi (2001) Case report: Is the invasion depth in millimeters valid to determine the prognosis of early invasive cervical adenocarcinoma? A case of recurrent FIGO stage IA 1 cervical adenocarcinoma. Gynecol Oncol 82 205-207.
87. HM Shingleton, H Gore, DH Bradley and S-J Soong (1981) Adenocarcinoma of the cervix: I. Clinical evaluation and pathologic features. Am J Obstet Gynecol 139 799-814.
88. LC Kilgore, S-J Soong, H Gore, et al. (1988) Analysis of prognostic features in adenocarcinoma of the cervix. Gynecol Oncol 31 137-148.
89. PJ Eifel, M Morris, MJ Oswald, et al. (1990) Adenocarcinoma of the uterine cervix: Prognosis and patterns of failure in 367 cases. Cancer 65 2507-2514.
90. P Hopkins, RW Schmidt, JA Roberts and GW Morley (1988) The prognosis and treatment of stage I adenocarcinoma of the cervix. Obstet Gynecol 72 915-921.
91. PJ Eifel, TW Burke, L Delclos, et al. (1991) Early stage I adenocarcinoma of the uterine cervix: Treatment results in patients with tumors ≤ 4 cm in diameter. Gynecol Oncol 41 199-205.
92. T Nakano, T Arai, S Morita and K Oka (1995) Radiation therapy alone for adenocarcinoma of the uterine cervix. Int J Radiation Oncol Biol Phys 32 1331-1336.
93. PJ Eifel, TW Burke, M Morris and TL Smith (1995) Adenocarcinoma as an independent risk factor for disease recurrences in patients with stage IB cervical carcinoma. Gynecol Oncol 59 38-44.
94. CM West, SE Davidson, PA Burt and RD Hunter (1995) The intrinsic radiosensitivity of cervical carcinoma: Correlations with clinical data. Int J Radiat Oncol Biol Phys 31 841-846.
95. MJ Costa, KR McIlny and J Trelford (1995) Cervical carcinoma with glandular differentiation: Histological evaluation predicts disease recurrence in clinical stage I or II patients. Hum Pathol 26 829-837.
96. R McLellan, MB Dillon, JD Woodruff, et al. (1994) Long term follow-up of stage I cervical adenocarcinoma treated by radical surgery. Gynecol Oncol 25 253-259.
97. J Levêque, JF Laurent, F Burtin, et al. (1998) Prognostic factors of the uterine cervix adenocarcinoma. Eur J Obstet Gynecol 80 209-214.
98. DF Silver, RE Hempling, MS Pivers, et al. (1998) Stage I adenocarcinoma of the cervix: Does lesion size affect treatment options and prognosis? Am J Clin Oncol 21 43-45.
99. DE Cohn, WA Peters III, HG Muntz, et al. (1998) Adenocarcinoma of the uterine cervix metastatic to lymph nodes. Am J Obstet Gynecol 18 1131-1137.
100. T Irie, J Kigawa, Y Minagawa, et al. (2000) Prognosis and clinico-pathological characteristics of Ib-IIb adenocarcinoma of the uterine cervix in patients who have had radical hysterectomy. Eur J Surg Oncol 26 464-467.
101. WA Peters III, PY Liu, RJ Barrett II, et al. (2000) Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix. Obstet Gynecol Surv 55 491-492.
102. PG Rose, SN Bundy, EB Watkins, et al. (1999) Concurrent cisplatin based radiotherapy and chemotherapy for locally advanced cervical cancer. N Engl J Med 340 1144-1153.
103. M Morris, PJ Eifel, J Lu, et al. (1999) Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. N Engl J Med 340 1137-1143.
104. M Crozier, M Morris, C Levenback, et al. (1995) Pelvic exenteration for adenocarcinoma of the uterine cervix. Gynecol Oncol 58 47-48.
105. GW Morley, MP Hopkins, SM Lindenauer and JA Roberts (1989) Pelvic exenteration, University of Michigan: 100 patients at 5 years. Obstet Gynecol 74 934-943.
106. RH Young and R Scully (1989) Villoglandular papillary adenocarcinoma of the uterine cervix: A clinicopathologic analysis of 13 cases. Cancer 63 1773-1779.
107. MW Jones, SG Silverberg and RJ Kurman (1993) Well-differentiated villoglandular adenocarcinoma of the uterine cervix: A clinico-pathological study of 24 cases. Int J Gynecol Pathol 12 1-7.
108. R-Y Chen, D-Y Change, M-L Yen, et al. (1998) Prognostic factors of primary adenocarcinoma of the uterine cervix. Gynecol Oncol 69 157-164.
109. MP Hopkins, P Sutton and JA Roberts (1987) Prognostic features and treatment of endocervical adenocarcinoma of the cervix. Gynecol Oncol 27 69-75.
110. L Nguyen, CA Brewer and PJ DiSaia (1998) Ovarian metastasis of stage IB1 squamous cell cancer of the cervix after radical parametrectomy and oophoropexy. Gynecol Oncol 68 198-200.
111. GP Sutton, BN Bundy, G Delgado, et al. (1992) Ovarian metastases in stage IB carcinoma of the cervix: A Gynecologic Oncology Group study. Am J Obstet Gynecol 166 50-53.
112. JV Brown, YS Fu and JS Berek (1990) Ovarian metastases are rare in stage I adenocarcinoma of the cervix. Obstet Gynecol 76 623-626.
113. R Yamamoto, K Okamoto, T Yukiharu, et al. (2001) A study of risk factors for ovarian metastases in Ib-IIIb cervical carcinoma and analysis of ovarian function after transpositions. Gynecol Oncol 82 312-316.
114. T Nakanishi, K Wakai, H Ishikawa, et al. (2001) A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix. Gynecol Oncol 82 504-509.
115. N Natsuma, Y Aoki, H Kase, et al. (1999) Ovarian metastasis in stage IB and II cervical adenocarcinoma. Gynecol Oncol 74 255-258.